Future prospects for cancer immunotherapy using induced pluripotent stem cell-derived dendritic cells or macrophages.

导出原文传递

翻译打印收藏纠错

作者： Satoshi,Fukushima ^[1] ; Azusa,Miyashita ^[1] ; Haruka,Kuriyama ^[1] ; Toshihiro,Kimura ^[1] ; Satoru,Mizuhashi ^[1] ; Yosuke,Kubo ^[1] ; Satoshi,Nakahara ^[1] ; Hisashi,Kanemaru ^[1] ; Nobuhiro,Tsuchiya ^[2] ; Hiroaki,Mashima ^[2] ; Rong,Zhang ^[2] ; Yasushi,Uemura ^[2]

作者单位： Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan. ^[1] Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center (NCC), Tokyo, Japan. ^[2]

关键词 cancer immunotherapy cell therapy dendritic cells iPS cells macrophages

主题词人类(Humans);诱导多能干细胞(Induced Pluripotent Stem Cells);免疫疗法(Immunotherapy);巨噬细胞(Macrophages);细胞因子类(Cytokines);树突细胞(Dendritic Cells);肿瘤(Neoplasms)

DOI 10.1111/exd.14729

PMID 36529534

发布时间 2023-03-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交